Emalex eyes FDA approval for Tourette syndrome therapy after Phase III success
The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients ...
Crain's Chicago Business3h
Chicago pharma gets good news on Tourette syndrome drug candidate
Ecopipam showed statistical significance in treating Tourette syndrome versus a placebo for both its primary efficacy ...
BioSpace5h
Emalex Heads to FDA After Phase III Tourette Syndrome Win
In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with ...
Sudbury7h
Sudbury officer cleared of breaking wrist during arrest
The man was arrested after holding a gun to a woman’s head, and no footage of the arrest or the interview show any injury to ...
Parade on MSN17h
Baylen Dupree Fans Celebrate TLC Star's Major Milestone
Baylen Dupree is excited about marking a huge milestone, and her fans are along for the ride. The TLC star got the news on ...
‘Baylen Out Loud’ Episode Guide: Where To Stream The TLC Show
Baylen Out Loud has become a huge hit for TLC, with over 14.7 million views across linear and streaming since its premiere in January, per Variety. The network says Baylen Out Loud is the most-watched ...
ENDPOINTS NEWS23h
Chica­go biotech Emalex says it cleared a Phase 3 for Tourette syn­drome, will seek FDA ap­proval
Emalex Biosciences said its daily oral tablet helped reduce relapses for children and adults with Tourette syndrome in a ...